leadf
logo-loader
viewInnoCan Pharma

Innocan Pharma launches Derma CBD line in Europe

Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive with news the company has launched their CBD derma line. Bincovich discusses where it is being made and the first areas of the world it is being rolled out to.

Bincovich also told gave Proactive an update on their Pharma work and how their capital raise is going.

Quick facts: InnoCan Pharma

Price: 0.435 CAD

CSE:INNO
Market: CSE
Market Cap: $76.43 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Corazon Mining identifies significant visual sulphide mineralisation in...

Corazon Mining Ltd's (ASX:CZN) (OTCMKTS:CRZNF) Brett Smith caught up with Proactive's Andrew Scott after receiving positive initial visual results from their current phase of drilling at the Lynn Lake Nickel-Copper-Cobalt Sulphide Project in Manitoba Province, Canada. The first hole FLC2021-24...

11 hours, 10 minutes ago

2 min read